Mission BioCapital
PE / VC · Cambridge · United States
Stages
Investment region
Industries
Profile
Mission BioCapital is a venture capital firm based in Cambridge, Massachusetts, founded in 2009. The firm is composed of scientists, investors, founders, and serial entrepreneurs with a focus on empowering life science entrepreneurs. They provide early-stage capital and support through a shared labs model, offering lab space and mentorship to accelerate the development of scientific solutions. The firm primarily invests in the life sciences and biotechnology sectors, focusing on early-stage companies. They typically invest up to $500K per company and offer additional services through their Platinum Program. Mission BioCapital invests in the United States and Europe, with a portfolio that includes companies like Alector, Pandion, and Mitokinin. They are currently investing out of their fifth fund, Mission BioCapital V LP, with an AUM of $275 million. Notable investments by Mission BioCapital include Alector - a biotechnology company, Pandion - a drug discovery firm, Mitokinin - a biotech company, Nocion Therapeutics - focused on drug discovery, and QurAlis - a biotech firm. These investments highlight their commitment to advancing life sciences and biotechnology innovations.
Contacts (2)
| Name | Title | Phone | ||
|---|---|---|---|---|
| Managing General Partner | — | — | — | |
| General Partner | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.